US NEWS FEEDS
A startup backed by Ohio State University and Ohio Third Frontier has closed a funding round of as much as $50 million toward bringing to market a drug-device combination as an alternative to prescribing opioids for pain.
Columbus-based Sollis Therapeutics Inc. can draw on the funding in stages as it completes studies and other steps toward approval by the U.S. Food and Drug Administration. Clinical trials are expected to begin soon, the company said in a news release.
New York City hedge fund…
Columbus Business News - Local Columbus News | Business First of Columbus
READ MORE >
Third Frontier-backed startup raises up to $50M for opioid-alternative development